Petach Tikvah, Israel (ots/PRNewswire) - The latest geographic growth increases Medison's global footprint across 25 countries in four continents, further strengthening its commercial offering Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients ...
Yavne, Israel (ots/PRNewswire) - Accessible First-Line Contactless Glaucoma Care Now Available in Europe BELKIN Vision, the Israel-based medical device company committed to bringing an accessible first-line glaucoma laser treatment to market, announced today that it has been awarded CE Mark under Medical Device Regulation (MDR) from its notified body DEKRA, making it the first automated, non-contact glaucoma laser ...
Milan (ots/PRNewswire) - The new platform will be presented at the next EACR Liquid Biopsy conference to be held in Bergamo, Italy, on May 24th-26th, 2022 Tethis S.p.A announces the release of See.d®, the first universal blood sample preparator for liquid biopsy analysis. This innovative technology performs a ...
POCARED Diagnostics; European Investment Bank
Rehovot, Israel (ots/PRNewswire) - - First EIB support for medtech investment in Israel - Financing to accelerate development of rapid testing system to improve infectious disease diagnosis and antibiotics stewardship - Automated phenotypic testing, revolutionizing infectious diseases diagnostics from sample to ...
Tübingen (ots) - Acousia Therapeutics GmbH will be presenting data on the company’s clinical stage, first-in-class lead candidate ACOU085 at the Hanson Wade 2nd Inner Ear Therapeutics Summit to be held in person in Boston (MA) from June 20–23, 2022. ACOU085 is a proprietary, first-in-class, small-molecule ...
Caesarea, Israel (ots/PRNewswire) - Cardiovascular study results to be presented by Prof. Ran Kornowski, Director of the Cardiology Center, Rabin Medical Center at the EuroPCR 2022 conference in May Filterlex Medical Ltd., a cardiovascular medical device startup, announced today that it has completed its CAPTIS ...
Berlin/Lausanne/Barcelona/Munich (ots) - New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company Fosanis to broaden patient access of Mika - an app-based DTx platform empowering people affected by cancer. Berlin-based digital health company Fosanis, the ...
Tübingen (ots) - ACOU085, the lead candidate from Acousia Therapeutics, has been administered to the first patient with age-related hearing loss (presbycusis) in a Phase 1b clinical study in Germany. The pre-screening of patients matching the comprehensive in/exclusion criteria for the ongoing trial is almost ...
Schweizerischer Nationalfonds / Fonds national suisse
Bern (ots) - Last year, the SNSF selected around 1800 research projects for funding. It also launched new funding measures because Swiss researchers are not able to participate in important areas of the Horizon Europe programme. Expanding knowledge and solving problems. That is what thousands of SNSF-funded research teams do at Swiss universities and other higher education institutions. Their curiosity and their ...
Nijmegen, Netherlands and Wedel, Germany (ots/PRNewswire) - SYD985 Marketing Authorization Application Soon to Be Submitted to the EMA Byondis B.V., an independent, Dutch clinical stage biopharmaceutical company creating precision medicines, has entered into a License and Collaboration Agreement and a Supply ...
Parma, Italy, and Cleveland, Ohio (ots/PRNewswire) - - New investment will progress treatment of pulmonary arterial hypertension (PAH), a rare condition which causes high blood pressure in the blood vessels that supply the lungs and can lead to heart failure. - Current approved medications mainly address the ...
London (ots/PRNewswire) - Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary to a PR Newswire announcement issued today indicating that Opiant Pharmaceuticals and Hikma have entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK. About Hikma ...
Barcelona, Spain (ots/PRNewswire) - - The agreement with Dana-Farber Cancer Institute consists of using HER2DX®️ to analyze tumor samples from more than 500 patients with early-stage HER2+ breast cancer across three clinical trials (APT, ATEMPT, and DAPHNE). - The three completed studies were essential in establishing new anti-HER2-based treatment strategies for ...
Heidelberg, Germany, and Cambridge, Mass. (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced that data from the second pivotal Phase 3 trial (ESSENCE-2) evaluating the investigational ...
Schweizerischer Nationalfonds / Fonds national suisse
Bern (ots) - A team of researchers supported by the Swiss National Science Foundation has developed a mathematical model that anticipates flu peaks in hospitals based on weather data. When too many people fall ill at the same time, hospitals run the risk of congestion, as the Covid-19 pandemic showed to a certain extent. The flu virus can cause the same problems. A team of researchers supported by the Swiss National ...
Tel Aviv, Israel (ots/PRNewswire) - BENDIT Technologies, a company focused on the development of a steerable microcatheter platform, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bendit21 microcatheter for treatment in the neuro, peripheral, and coronary ...
Zug, Switzerland (ots/PRNewswire) - In a new publication, the company's flagship compound proves effective in targeting the harmful pathogen while preserving a healthy microbiome Micreos Pharmaceuticals today announces findings from a study proving the effectiveness of XZ.700, a novel antibacterial enzyme, in ...
Aberdeen, Scotland and Singapore (ots/PRNewswire) - - Significant milestone in the only late-stage clinical trial targeting tau pathology of Alzheimer's - TauRx on track to announce top line results in May - Trial aims to confirm efficacy of first tau-based treatment for Alzheimer's TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer's Disease (AD) research, has announced that the last patient has completed ...
Oxford, England (ots/PRNewswire) - - Oxitec's team of experts will advance development and pilot validation of the Friendly™ mosquito platform to combat two malaria-spreading mosquitoes: the invasive Anopheles stephensi, predicted to cause urban malaria epidemics across Africa; and Anopheles albimanus, which is ...
New York (ots/PRNewswire) - Mindtree, a global technology services and digital transformation company, today announced that it has made a strategic investment in COPE Health Solutions, a leading U.S. healthcare consulting, implementation, and co-management leader in value-based care and payment, workforce development and data analytics, to expand its healthcare ...
Schweizerischer Nationalfonds / Fonds national suisse
Bern (ots) - Artificial intelligence helps to detect burnout. Researchers supported by the Swiss National Science Foundation have developed a promising technique based on automatic analysis of text data. Burnout refers to a state of profound physical and mental exhaustion. It is difficult to detect because its symptoms can overlap with those of depression and anxiety. But artificial intelligence may hold the key to better ...
Beverly Hills, CA (ots) - --News Direct-- Premier Beverly Hills-based dermatology practice, Lancer Dermatology, announced today that it has partnered with Forefront Dermatology, the largest physician-led single specialty group providing dermatological services in the United States with over 200+ dermatology practices. The collaboration with Forefront Dermatology will ...
Parma, Italy (ots/PRNewswire) - - 2021 Turnover €2.42bn - up 8.6% - Internationally China up 22%, US up >10% - Continued focus on innovation: almost 20% of turnover invested in R&D - Chiesi recognised as Top Employer in eight markets and as Top Employer Europe for 10th consecutive year Growth continues at Chiesi, the international research-focussed pharmaceutical group and its 30 global affiliates with turnover at €2.42bn, up 8.6% vs 2020. Gross operating profit (EBITDA) ...
Newport Beach (ots) - Proceeds to accelerate the collection and use of wearable sensor data in clinical trials along with the development of novel digital biomarkers Funding round co-led by the Perceptive Xontogeny Venture (PXV) Fund and Switzerland-based Debiopharm Innovation Fund VivoSense, Inc., (“VivoSense”) an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor ...
New York (ots/PRNewswire) - Creating an end-to-end pharmaceutical product commercialization and launch excellence capability that optimizes and accelerates patient access to medical advances Lumanity today announced the acquisition of Innovative Edge ("IE"), a leading provider of pharmaceutical product launch services. The terms of the transaction were not disclosed. IE partners with world-leading biopharma companies – from Top 20 pharmaceutical manufacturers to ...
Kfar Saba, Israel (ots/PRNewswire) - Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint CartiHeal Ltd, developer of implants for the treatment of cartilage and ...
Aachen, Germany, and Raleigh, North Carolina (ots) - Grünenthal and NovaQuest announced today that they have entered into an agreement to advance the global clinical Phase III programme of Grünenthal's asset resiniferatoxin (RTX). The investigational medicine is being developed with the aim of providing patients ...
Dhahran, Saudi Arabia (ots/PRNewswire) - - The inaugural Sync Digital Wellbeing Summit (29-30 March) will raise awareness of the hidden realities of our relationship with digital services - Leadership from IBM, UNESCO and Childnet amongst those speaking at sessions across the two-day Summit - Full Summit agenda can ...